Crusader seem to be in the late stages of the Orphan/Institutional Investment stage, grounds for significant upside in the cycle if the investment cash is advanced
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025